GBIM Trademark

Trademark Overview

On Friday, April 20, 2012, a trademark application was filed for GBIM with the United States Patent and Trademark Office. The USPTO has given the GBIM trademark a serial number of 85603815. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, December 12, 2025. This trademark is owned by GLOBEIMMUNE, INC.. The GBIM trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

[ Immunotherapy products, namely, pharmaceutical preparations for treatment of cancer and infectious disease; therapeutic and prophylactic vaccines ]

Research and development of immunotherapy products, pharmaceutical products, and vaccine products for others
gbim

General Information

Serial Number85603815
Word MarkGBIM
Filing DateFriday, April 20, 2012
Status710 - CANCELLED - SECTION 8
Status DateFriday, December 12, 2025
Registration Number4748281
Registration DateTuesday, June 2, 2015
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 5, 2013

Trademark Statements

Goods and Services[ Immunotherapy products, namely, pharmaceutical preparations for treatment of cancer and infectious disease; therapeutic and prophylactic vaccines ]
Pseudo MarkGLOBE IMMUNE
Goods and ServicesResearch and development of immunotherapy products, pharmaceutical products, and vaccine products for others

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeB - Sec. 8 - Class(es) in a Multiple Class registration
Class Status DateFriday, September 11, 2020
Primary Code005
First Use Anywhere DateMonday, April 13, 2015
First Use In Commerce DateMonday, April 13, 2015
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, December 12, 2025
Primary Code042
First Use Anywhere DateTuesday, November 4, 2014
First Use In Commerce DateTuesday, November 4, 2014

Trademark Owner History

Party NameGLOBEIMMUNE, INC.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressLouisville, CO 80027
Party NameGLOBEIMMUNE, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressLouisville, CO 80027
Party NameGLOBEIMMUNE, INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressLouisville, CO 80027

Trademark Events

Event DateEvent Description
Tuesday, April 24, 2012NEW APPLICATION ENTERED
Friday, April 27, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, April 28, 2012NOTICE OF PSEUDO MARK MAILED
Tuesday, August 7, 2012ASSIGNED TO EXAMINER
Tuesday, August 7, 2012NON-FINAL ACTION WRITTEN
Tuesday, August 7, 2012NON-FINAL ACTION E-MAILED
Tuesday, August 7, 2012NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, January 14, 2013TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, January 14, 2013CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, January 14, 2013TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, January 15, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, January 26, 2013ASSIGNED TO LIE
Monday, January 28, 2013LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, February 13, 2013NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 5, 2013PUBLISHED FOR OPPOSITION
Tuesday, March 5, 2013OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 30, 2013NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, October 9, 2013SOU TEAS EXTENSION RECEIVED
Wednesday, October 9, 2013SOU EXTENSION 1 FILED
Wednesday, October 9, 2013SOU EXTENSION 1 GRANTED
Saturday, October 12, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 2, 2014SOU TEAS EXTENSION RECEIVED
Tuesday, April 22, 2014CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, April 2, 2014SOU EXTENSION 2 FILED
Wednesday, April 23, 2014SOU EXTENSION 2 GRANTED
Thursday, April 24, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, October 30, 2014SOU TEAS EXTENSION RECEIVED
Thursday, October 30, 2014SOU EXTENSION 3 FILED
Wednesday, November 12, 2014SOU EXTENSION 3 GRANTED
Thursday, November 13, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, April 23, 2015TEAS STATEMENT OF USE RECEIVED
Thursday, April 23, 2015USE AMENDMENT FILED
Monday, April 27, 2015STATEMENT OF USE PROCESSING COMPLETE
Tuesday, April 28, 2015ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, April 29, 2015NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, June 2, 2015REGISTERED-PRINCIPAL REGISTER
Tuesday, June 2, 2020COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Thursday, June 11, 2020TEAS SECTION 8 & 15 RECEIVED
Monday, August 31, 2020CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, September 11, 2020REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Friday, September 11, 2020NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Sunday, June 2, 2024COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Friday, December 12, 2025CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9

Related Keywords

gbim products immunotherapy pharmaceutical vaccines research vaccine others prophylactic development infectious